Enzyme was founded by Jared Seehafer, Jacob Graham in 2017.

Who are Enzyme's investors?

Enzyme's investors include Y Combinator, Ag Startup Engine Seed, Refactor Capital, Sahsen Ventures.

Where is Enzyme headquartered?

Enzyme is headquartered in San Francisco, US.

Enzyme

San Francisco, US · Founded 2017 · 32 employees · 4 known investors

Find your way into Enzyme

516 people in our graph share verified history with the Enzyme team — schools, employers, funds. One of them is your warm intro.

Ben Coughlanunlockedknows Jacob Graham · together at Boston Scientific (overlapped)

×7knows the team · via Y Combinator

×2knows the team · via Villageglobal

×2knows the team · via Village Global

Enzyme develops a Quality Management System (QMS) software platform for life science companies including drug, biologic, device, and digital product manufacturers, designed to streamline regulatory workflows and generate FDA-ready documentation.

Enterprise Software Healthtech Medical Devices SaaSUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S17)

Enzyme was founded in 2017 by Jared Seehafer and Jacob Graham.

Jared Seehafer in 𝕏CEO & Cofounder2016–2025Jared Seehafer is a former founder and CEO who previously worked in policy at the FDA and attended Y Combinator.

Jacob Graham inChief Operating Officer & Cofounder2022–2024He brings over 10 years of engineering and management experience in medical device quality, regulatory compliance, and design controls, including work on catheter-based implants and multiple Class II and III device commercializations, and previously cofounded a B2B SaaS eQMS startup that achieved an exit.

Investors · 4

Y CombinatorSan Francisco · $500K

Ag Startup Engine SeedreportedAmes

Refactor CapitalreportedBurlingame · $1M – $2M

Sahsen VenturesreportedSeattle

Competitors · 1

by search overlap

Greenlight Guru31 shared keywordsGreenlight Guru provides quality management, product development, and clinical evidence software built specifically for medical device companies. Its platform helps medtech teams manage compliance, design controls, risk, and clinical data collection across the product lifecycle.

Companies competing with Enzyme for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

ZymeCO Raises $4 Million Series A to Scale Enzyme Bio-Manufacturing for Turf Management and Agricultural Crop Residue Managementzymecompany.com · Jul 2026

Manchester Spinout Imperagen Raises £5M in Seed Funding to Deploy Quantum Physics, AI Modelling and Automated Labs for Enzyme Engineeringthequantuminsider.com · May 2026

Imperagen Raises €5 . 8M Seed for AI and Quantum Enzyme Engineeringsci-tech-today.com · May 2026

Biotech Innovation: Alcolase Raises €1.5M for Enzyme Therapy - AI CERTs Newsaicerts.ai · May 2026

Frequently asked questions

What does Enzyme do?: Enzyme develops a Quality Management System (QMS) software platform for life science companies including drug, biologic, device, and digital product manufacturers, designed to streamline regulatory workflows and generate FDA-ready documentation.
Who founded Enzyme?: Enzyme was founded by Jared Seehafer, Jacob Graham in 2017.
Who are Enzyme's investors?: Enzyme's investors include Y Combinator, Ag Startup Engine Seed, Refactor Capital, Sahsen Ventures.
Where is Enzyme headquartered?: Enzyme is headquartered in San Francisco, US.